A. Krasnianski

发表

Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.

B. Steinhoff, K. Kallenberg, U. Heinemann, 2007, Brain : a journal of neurology.

MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter‐observer agreement study

K. Kallenberg, U. Heinemann, A. Krasnianski, 2008, European journal of neurology.

Novel PRNP mutation in a patient with a slow progressive dementia syndrome.

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2008, Medical science monitor : international medical journal of experimental and clinical research.

Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2006, BMC neurology.

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis

K. Hess, C. V. van Duijn, A. Krasnianski, 2007, Journal of Neurology.

Differenzialdiagnose rasch progredienter Demenzen

U. Heinemann, A. Krasnianski, B. Meissner, 2007 .

Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies.

A. Krasnianski, B. Schoser, M. Krasnianski, 2005, Brain : a journal of neurology.

Fatal familial insomnia: Clinical features and early identification

U. Heinemann, A. Krasnianski, B. Meissner, 2008, Annals of neurology.

Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.

U. Heinemann, A. Krasnianski, B. Meissner, 2008, Journal of Alzheimer's disease : JAD.

Clinical Features and Diagnosis of the MM 2 Cortical Subtype of Sporadic Creutzfeldt-Jakob Disease

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2006 .

Brain biopsy in patients with suspected Creutzfeldt-Jakob disease.

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2008, Journal of neurosurgery.

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

M. Gobbi, F. Sedel, J. Laplanche, 2014, The Lancet Neurology.

Clinical course in young patients with sporadic Creutzfeldt–Jakob disease

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2005, Annals of neurology.

14-3-3 CSF levels in sporadic Creutzfeldt–Jakob disease differ across molecular subtypes

U. Heinemann, A. Krasnianski, B. Meissner, 2009, Neurobiology of Aging.

Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt−Jakob disease

U. Heinemann, A. Krasnianski, I. Zerr, 2016, European journal of neurology.

Doxycycline in early CJD: a double-blinded randomised phase II and observational study

Tim Friede, Walter J Schulz-Schaeffer, T. Friede, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

A proposal of new diagnostic pathway for fatal familial insomnia

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

U. Heinemann, A. Krasnianski, D. Varges, 2011, Journal of Alzheimer's disease : JAD.

First symptom and initial diagnosis in sporadic CJD patients in Germany

H. Kretzschmar, A. Krasnianski, I. Zerr, 2014, Journal of Neurology.

MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease

K. Kallenberg, U. Heinemann, A. Krasnianski, 2009, Journal of Neurology.

Molecular subtype-specific clinical diagnosis of prion diseases.

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2007, Veterinary microbiology.

Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.

U. Heinemann, A. Krasnianski, B. Meissner, 2009, Journal of Alzheimer's disease : JAD.

Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2006, Archives of neurology.

Sporadic Creutzfeldt–Jakob disease

K. Kallenberg, A. Krasnianski, B. Meissner, 2005, Neurology.

Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD.

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2006, Brain : a journal of neurology.

Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.

U. Heinemann, A. Krasnianski, B. Meissner, 2004, Folia neuropathologica.

Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease

K. Kallenberg, U. Heinemann, A. Krasnianski, 2008, American Journal of Neuroradiology.

Clinical findings and diagnosis in genetic prion diseases in Germany

K. Kallenberg, H. Kretzschmar, U. Heinemann, 2015, European Journal of Epidemiology.

Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany.

A. Krasnianski, I. Zerr, M. Harden, 2015, The Journal of clinical psychiatry.

Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study.

E. Gouzoulis-Mayfrank, K. Schnell, A. Krasnianski, 2014, The American journal on addictions.

Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type

K. Kallenberg, H. Kretzschmar, A. Krasnianski, 2005 .

Increased frequency of positive family history of dementia in sporadic CJD

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2009, Neurobiology of Aging.

Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.

U. Heinemann, A. Krasnianski, B. Meissner, 2017, Journal of Alzheimer's disease : JAD.

Reply to 'Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies--a comment'.

A. Krasnianski, M. Krasnianski, S. Zierz, 2006, Brain : a journal of neurology.

False-positive diagnosis of a single, large-scale mitochondrial DNA deletion by Southern blot analysis: the role of neutral polymorphisms.

Robert W. Taylor, A. Krasnianski, S. Zierz, 2004, Genetic testing.

ApoE Distribution and Family History in Genetic Prion Diseases in Germany

H. Kretzschmar, U. Heinemann, A. Krasnianski, 2007, Journal of Molecular Neuroscience.

ORIGINAL RESEARCH Isolated Cortical Signal Increase on MR Imaging as a Frequent Lesion Pattern in Sporadic Creutzfeldt-Jakob Disease

K. Kallenberg, U. Heinemann, A. Krasnianski, 2008 .

Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.

U. Heinemann, A. Krasnianski, B. Meissner, 2009, Journal of Alzheimer's disease : JAD.